Press Releases

• Company Receives Patent on Rapid Thermocycling Methodology for Molecular Diagnostics
  06/22/2009
  Micronics, Inc. today announced that it has been issued a letters patent from the United States Patent and Trademark Office (USPTO) for a system and method for performing rapid thermocycling on a microfluidic device.



• Micronics Acquires License to Molecular Beacons Technology
  06/01/2009
  Micronics, Inc., a leading developer of point-of-care molecular and immunohematology diagnostic products, announced today that it has entered into a license agreement with PHRI Properties, Inc., a nonprofit corporation wholly owned by the University of Medicine & Dentistry of New Jersey, for the right to make, have made, use and sell Micronics’ products that incorporate PHRI’s molecular beacons technology.



• Micronics Completes Series C Financing
  10/16/2008
  Micronics, Inc., a leading developer of molecular and immuno-hematology diagnostic products, announced today that it has completed a Series C financing lead by the Southwest Michigan First (SWMF) Life Science Fund.



• Micronics Receives Two New Patents on Microfluidic Technologies
  09/29/2008
  Micronics, Inc. today announced that it has been issued two patents from the United States Patent and Trademark Office (USPTO) for novel microfluidic devices and methods.



• Micronics Names Larry Hambleton as Vice President of Sales and Marketing
  07/15/2008
  Molecular products background augments company’s product focus